Poster sale · Free shipping over $80 · Red tag edit
Login Reg

TAS SANIT SABA CONF MZLLA REG A14 LABORATORIOS ALFASIGMA MEXICO SA DE CV Carcinoma hepatocelular tratado previamente con

SKU 42574115192
4.4
USD41.89 USD78.89

Pay in 4 interest-free payments of $10.47 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

TAS SANIT SABA CONF MZLLA REG A14 LABORATORIOS ALFASIGMA MEXICO SA DE CV Carcinoma hepatocelular tratado previamente con
TAS SANIT SABA CONF MZLLA REG A14 LABORATORIOS ALFASIGMA MEXICO SA DE CV Carcinoma hepatocelular tratado previamente con
TAS SANIT SABA CONF MZLLA REG A14 LABORATORIOS ALFASIGMA MEXICO SA DE CV Carcinoma hepatocelular tratado previamente con
TAS SANIT SABA CONF MZLLA REG A14 LABORATORIOS ALFASIGMA MEXICO SA DE CV Carcinoma hepatocelular tratado previamente con
Description

Carcinoma hepatocelular tratado previamente con sorafenib

DOSIS: 60/25 MG

TASIGNA 200 mg | Cápsulas | Nilotinib | Novartis

COFEPRIS: 338M96 SSA VI

TAS SANIT SABA CONF MZLLA REG A14 LABORATORIOS ALFASIGMA MEXICO SA DE CV Carcinoma hepatocelular tratado previamente conPresentacin en empaque con 14 toallas.

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products